Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia

Bone Marrow Transplantation

Volumn 23, Issue 12, 1999, Pages 1279-1282

  Vellenga, E ^c   Van Putten, W L J ^b   Boogaerts, M A ^h   Daenen, S M G J ^c   Verhoef, G E G ^h   Hagenbeek, A ^f   Jonkhoff, A R ^d   Huijgens, P C ^d   Verdonck, L F ^f   Van Der Lelie, J ^e   Schouten, H C ^h   Gmur J ^h   Wijermans, P ^g   Gratwohl, A ^h   Hess, U ^h   Fey, M F ^h   Lowenberg B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Hovon Data Center   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g LEYENBURG HOSPITAL   (Netherlands)

^h Department of Hematology ^*

Author keywords

AML; G CSF; Peripheral stem cell mobilization and transplantation

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; FEASIBILITY STUDY; FEMALE; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

EID: 0033516330     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701799     Document Type: Article

References (14)

1. Löwenberg B. Post-remission treatment of acute myelogenous leukemia. New Engl J Med 1995; 332: 260-262.
2. Löwenberg B, Verdonck LJ, Dekker AW et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990; 8: 287-294.
3. Cassileth PA, Andersen J, Lazarus HM et al. Autologous bone marrow transplant in acute leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
4. Zittoun R, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
5. Burnett AK, Goldstone AH, Stevens RMF et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML10 trial. Lancet 1998; 351: 700-707.
6. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357.
7. Vellenga E, Sizoo W, Hagenbeek A et al. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation. Br J Haematol 1997; 65: 137-142.
8. French-American-British (FAB) Cooperative Group. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-630.
9. Löwenberg B, Boogaerts MA, Daenen SM et al. Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol 1997; 15: 3496-3506.
10. Mayer RJ, Davis RB, Schiffer CA et al. Intensive post-remission chemotherapy in adults with acute myeloid leukemia. New Engl J Med 1994; 331: 896-903.
11. Bishop JF, Matthews JP, Young GA et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 1996; 87: 1710-1717.
12. Appelbaum FR, Fisher LD, Thomas ED et al. Chemotherapy versus marrow transplantation for adults with acute non-lymphocytic leukemia: a five-year follow-up. Blood 1988; 72: 178-184.
13. Demirer T, Buckner CD, Appelbaum FR et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
14. Jowitt SN, Chang J, Morgenstern GR et al. Factors which affect the CFU-GM content of the peripheral blood haematopoietic progenior cell harvest in patients with acute myeloid leukaemia. Br J Haematol 1998; 100: 688-694.